2.34
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | 109.16 | 4.173 | 0.791 |
|
|
4.21%
36.12
|
34.66 | 34.99 | 41.46 | 35.58 |
| Benefits Costs and Expenses |
47.15%
34.43
|
65.14 | - | 38.47 | 32.02 |
| Costs And Expenses |
47.15%
34.43
|
65.14 | - | 38.47 | 32.02 |
| Operating Income/Loss |
4.21%
-36.12
|
-34.66 | 74.18 | -37.28 | -34.79 |
| Nonoperating Income/Loss |
19.83%
1.702
|
2.123 | 2.384 | 2.987 | 3.555 |
| Income/Loss From Continuing Operations Before Tax |
5.78%
-34.42
|
-32.54 | 76.56 | -34.30 | -31.23 |
| Income/Loss From Continuing Operations After Tax |
5.78%
-34.42
|
-32.54 | 76.56 | -36.07 | -31.23 |
|
|
5.78%
-34.42
|
-32.54 | 76.56 | -36.07 | -31.23 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.26%
86.46
|
86.24 | 86.02 | 2.2547 | 84.70 |
| Diluted Average Shares |
0.26%
86.46
|
86.24 | 86.10 | 2.2547 | 84.70 |
| Basic Earnings Per Share |
5.26%
-0.40
|
-0.38 | 0.89 | -0.43 | -0.37 |
| Diluted Earnings Per Share |
5.26%
-0.40
|
-0.38 | 0.89 | -0.43 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):